We and others previously reported the link of Bcl-xL protein expression not only with drug resistance in different tumor histotypes [27], but also with tumor-associated properties, including angiogenesis and cancer cell stemness [34,49,50,51,52]. The gene discussed is BCL2L1; the disease is cancer.